Results 231 to 240 of about 81,393 (255)
Some of the next articles are maybe not open access.

Beneficial Effect of Interleukin-1 Receptor Antagonist Protein on Spinal Cord Injury Recovery in the Rat

Inflammation, 2011
We assessed the effect of treatment with the interleukin-1 receptor antagonist protein (IRAP) on morphological and functional recovery in a rat model of SCI. All sections were processed for immunohistochemistry, hematoxylin-eosin, and Nissl staining. Rats were assessed for hind limb motor function using the Basso, Beattie, and Bresnahan (BBB) hind limb
Shaohui, Zong   +4 more
openaire   +2 more sources

Characterization of an interleukin 1 receptor antagonist protein released from ultraviolet-irradiated epidermal sheet

Journal of Dermatological Science, 1997
An interleukin 1 (IL-1) inhibitor was detected in the culture supernatant of mouse epidermal sheet which had been irradiated with middle-wavelength ultraviolet (UVB) either in vitro or in vivo. Properties of the IL-1 inhibitor were consistent with those of IL-1 receptor antagonist (IL-1ra), i.e., approximate molecular size of 17 kDa by gel filtration ...
T, Hirao, H, Aoki, H, Ichikawa, Y, Sato
openaire   +2 more sources

Generation of a Transgenic Mouse with Lung-specific Overexpression of the Human Interleukin-1 Receptor Antagonist Protein

American Journal of Respiratory Cell and Molecular Biology, 1998
Abstract The purpose of the studies described here was to test the hypothesis that overexpression of the human interleukin-1 receptor antagonist (IL-1ra) in the distal airway epithelia of mice would result in amelioration of the inflammatory effects of IL-1α.
R W, Wilmott   +3 more
openaire   +2 more sources

Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist

International Journal of Biochemistry, 1994
1. The role of interleukin-1 (IL-1) in sepsis-induced muscle proteolysis was assessed by treating septic rats with recombinant IL-1 receptor antagonist (rIL-1ra). 2. In initial experiments, we tested the effectiveness of IL-1ra in preventing muscle proteolysis induced by administration of IL-1. 3.
O, Zamir   +5 more
openaire   +2 more sources

Immunohistochemical demonstration of interleukin-1 receptor antagonist protein and interleukin-1 in human lymphoid tissue and granulomas.

The American journal of pathology, 1992
Human interleukin 1 receptor antagonist protein (IRAP) is a specific antagonist of interleukin 1 (IL-1) action in both in vitro and in vivo experimental models. Presently, the significance of this protein in human pathophysiology is unknown. In the present study, monoclonal antibodies against IRAP were prepared and used to demonstrate IRAP expression ...
S W, Chensue   +3 more
openaire   +1 more source

Combined Treatment of Acute EAE in Lewis Rats with TNF-Binding Protein and Interleukin-1 Receptor Antagonist

Experimental Neurology, 1998
Experimental autoimmune encephalomyelitis (EAE) is a term given to describe a collection of animal models representing the human disease multiple sclerosis (MS). Although not fully understood, the involvement of cytokines and the immune system in either EAE or human MS is well established.
B, Wiemann   +7 more
openaire   +2 more sources

The effects of interleukin-1 receptor antagonist protein (IRAP) infusion following spinal cord transection in rats

Molecular and Chemical Neuropathology, 1996
A laminectomy was performed at the T5-T6 vertebral level in adult, male, Sprague-Dawley rats and the spinal cord transected with a scalpel. A group of sham animals was subjected to the same surgery without the transection step. A group of unhandled control rats was also included. A subgroup of transected animals received a subcutaneous osmotic minipump
J B, Gelderd   +5 more
openaire   +2 more sources

INTERLEUKIN-8 SECRETION AND 15-LIPOXYGENASE ACUVTTY IN RHEUMATOID ARTHRITIS: IN VITRO ANTI-INFLAMMATORY EFFECTS BY INTERLEUKIN-4 AND INTERLEUKIN-10, BUT NOT BY INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN

Rheumatology, 1994
We have examined the ability of interleukin-4 (IL-4), interleukin-10 (IL-10) and interleukin-1 receptor antagonist protein (IL-1ra) to regulate spontaneous interleukin-8 (IL-8) production in cultured SF mononuclear cells (SFMC) from RA. Furthermore, we examined whether IL-4, IL-10, or IL-1ra could influence the production of the arachidonic acid ...
Deleuran, B; id_orcid 0000-0002-7079-1587   +6 more
openaire   +3 more sources

Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans.

Cancer research, 1993
Sustained release or high levels of interleukin-1 (IL-1) and/or tumor necrosis factor (TNF), as observed after endotoxin challenge, can produce a variety of toxicities. Naturally occurring inhibitors to IL-1 and TNF, IL-1 receptor antagonist (IL-1ra) and soluble TNF receptor forms, have been detected.
M J, Bargetzi   +6 more
openaire   +1 more source

Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide-stimulated human whole blood.

The American journal of pathology, 1992
Interleukin-8 (IL-8) is a neutrophil and lymphocyte chemoattractant and activator that may play an important role in mediating events at sites of inflammation. IL-8 is produced by many cell types in response to a variety of inducers, including interleukin-1 (IL-1).
L E, DeForge   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy